This course has expired. View available courses.
Rheumatology
Psoriatic arthritis – treating beyond the joint with anti-IL-17 medicines – Certificate of Completion
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease which shares characteristic clinical features, genetic markers and family history with the larger group of seronegative spondyloarthopathies. The diverse clinical picture of PsA, including joint involvement, dactylitis, enthesitis, skin lesions of psoriasis and uveitis, indicates a need to identify suitable therapies to address different combinations of these manifestations.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
Unaccredited
EXPIRY DATE
2020-06-07
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease which shares characteristic clinical features, genetic markers and family history with the larger group of seronegative spondyloarthopathies. The diverse clinical picture of PsA, including joint involvement, dactylitis, enthesitis, skin lesions of psoriasis and uveitis, indicates a need to identify suitable therapies to address different combinations of these manifestations.
Faculty
Associate Professor Paul Bird,
BMed (Hons), FRACP, PhD, Grad Dip MRI
St George & Sutherland Clinical School
University of New South Wales
VMO, St George Private Hospital, Kogarah, NSW
Associate Professor Peter A. Foley,
MB BS, BMedSc, MD, FACD
Senior Lecturer in Dermatology
Department of Medicine (Dermatology)
University of Melbourne, St Vincent's Hospital